65870-53-3 | 2-Quinoxalinecarboxaldehyde,2-[(2-hydroxyphenyl)methylene]hydrazone 1,4-dioxide | C16H12 N4 O3 |
65870-42-0 | (5alpha,6alpha,7alpha,22R)-5,17,20-trihydroxy-6,7:22,26-diepoxyergosta-2,24-diene-1,26-dione |
65870-52-2 | Cephalexin sodium impurity VI | C16H17N3O4S |
65870-94-2 | Hexanoic acid, 3,5,5-trimethyl-, 2-ethyl-2-[[(3,5,5-trimethyl-1-oxohexyl)oxy]methyl]-1,3-propanediyl ester | C33H62O6 |
65870-36-2 | 2-Naphthalenesulfonic acid, 5,5'-[oxybis[(2-amino-4,1-phenylene)azo]]bis[6-amino-, disodium salt | C32H26N8O7S2.2Na |
65870-41-9 | 7H-Furo[3,2-g][1]benzopyran-7-one, 9-(acetyloxy)-2-[1-(acetyloxy)-1-methylethyl]-2,3-dihydro- | C18H18O7 |
65870-63-5 | 2,5-Cyclohexadien-1-one, 2-iodo-4-[3-iodo-2-methyl-5-(1-methylethyl)-4-oxo-2,5-cyclohexadien-1- ylidene]-3-methyl-6-(1-methylethyl)- | C20H22I2O2 |
65870-95-3 | Hexanoic acid, 3,5,5-trimethyl-, 2-methyl-2-[[(3,5,5-trimethyl-1-oxohexyl)oxy]methyl]-1,3-propanediyl ester | C32H60O6 |